Speech-Language Pathologists in Jefferson, LA Accepting Medicare
7 Speech-Language Pathologists found. Showing 1 - 7
 Heather P. Adams, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 101 River Rd Ste 112, Jefferson, LA 70121 Phone: 504-828-7696 |
Anna G Weller, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 101 River Rd, Jefferson, LA 70121 Phone: 504-828-7696 |
Aileen Minihan Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1108 Shrewsbury Rd, Jefferson, LA 70121 Phone: 504-233-4720 |
Laura Everson Landry Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 101 River Rd, Suite 112, Jefferson, LA 70121 Phone: 504-828-7696 Fax: 504-828-8935 |
Evelyn Ashton-jones, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 316 Central Ave, Jefferson, LA 70121 Phone: 504-731-3471 |
Allison Mcintosh, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 101 River Rd Ste 112, Jefferson, LA 70121 Phone: 504-828-7696 |
Sarah P Anderson, MCD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 101 River Rd, Suite 112, Jefferson, LA 70121 Phone: 504-828-7696 Fax: 504-828-8935 |
News Archive
Globavir agrees to exclusively license novel oncology compound to Sorrento Therapeutics
Globavir Biosciences, Inc., a specialty biotechnology company developing small molecule drugs to treat cancer and infectious diseases, and Sorrento Therapeutics, Inc., an oncology company developing new treatments for cancer and associated pain, announced today that the companies have entered into an agreement under which Globavir exclusively licensed its novel oncology compound, BC001, to Sorrento Therapeutics.
Leadless pacemaker technology shows promising performance after 12 months
Vivek Reddy, MD, Director of Arrhythmia Services for The Mount Sinai Hospital, reported his promising12-month follow-up data showing the world's first leadless pacemaker is demonstrating overall device performance comparable to conventional pacemakers. Dr. Reddy presented the one-year LEADLESS study data findings during his late-breaking clinical trial presentation on May 9 at Heart Rhythm 2014, the Heart Rhythm Society's 35th Annual Scientific Sessions in San Francisco, CA.
Video can effectively reduce anxiety in children undergoing inhaled induction
Research by Dalhousie University student Katherine Mifflin has found that having children watch a video immediately prior to surgery can reduce their anxiety during anesthesia induction, the most stressful time for children throughout the perioperative process.
Combination therapy may be effective option for treating some women with ovarian cancer
Researchers have been trying to understand why up to 85 percent of women experience recurrence of high-grade serous ovarian cancer - the most common subtype of ovarian cancer - after standard treatment with the chemotherapy drug carboplatin.
Free bus pass increases physical activity in elderly
UK adults aged 60 years and over who take advantage of the 2002 introduction of a free bus pass undertake significantly more active travel than their peers who do not have a pass, indicate study results.
› Verified 2 days ago
Physical Therapists
Occupational Therapists
Speech-Language Pathologists
Optometrists
Audiologists